Neural restrictive silencer factor and choline acetyltransferase expression in cerebral tissue of Alzheimer's disease patients: A pilot study

Genetics and Molecular Biology

Volumn 36, Issue 1, 2013, Pages 28-36

  González Castañeda, Rocío E ^a,b,c   Sánchez González, Víctor J ^a   Flores Soto, Mario ^d   Vázquez Camacho, Gonzalo ^c,e   Macías Islas, Miguel A ^e   Ortiz, Genaro G ^a,b,c  

^a Lab Neurobiol Cel Y Molec   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^d UNIVERSITY OF GUADALAJARA   (Mexico)

^e HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Alzheimer's disease; Brain; Choline acetyltransferase; Neural restrictive silencer factor; Protein expression

Indexed keywords

CHOLINE ACETYLTRANSFERASE; ISOTHIOCYANIC ACID DERIVATIVE; NEURAL RESTRICTIVE SILENCER FACTOR; RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CHAT GENE; CONTROLLED STUDY; ENTORHINAL CORTEX; FRONTAL CORTEX; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NRSF GENE; NUCLEOTIDE SEQUENCE; PARIETAL CORTEX; PILOT STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TEMPORAL CORTEX; WESTERN BLOTTING;

EID: 84874824211     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/s1415-47572013000100005     Document Type: Article

References (69)

1. Abel C, Allegri RF, Garau L, Genovese O and Mangone CA (2008) Treatment of Alzheimer's Disease cognitive symptoms. Vertex 19(Suppl):39-47.
2. Auld DS, Kornecook TJ, Bastianetto S and Quirion R (2002) Alzheimer's disease and the basal forebrain cholinergic system: Relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68:209-245.
3. Belyaev ND, Wood IC, Bruce AW, Street M, Trinh JB and Buckley NJ (2004) Distinct RE-1 silencing transcription factor-containing complexes interact with different target genes. J Biol Chem 279:556-561.
4. Berrard S, Varoqui H, Cervini R, Israel M, Mallet J and Diebler MF (1995) Coregulation of two embedded gene products, choline acetyltransferase and the vesicular acetylcholine transporter. J Neurochem 65:939-942.
5. Berse B and Blusztajn JK (1995) Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor alpha, cAMP, and leukemia inhibitory factor/ciliary neurotrophic factor signaling pathways in a murine septal cell line. J Biol Chem 270:22101-22104.
6. Bessis A, Salmon AM, Zoli M, Le Novere N, Picciotto M and Changeux JP (1995) Promoter elements conferring neuron-specific expression of the beta 2-subunit of the neuronal NRSF & ChAT in brain tissue of AD nicotinic acetylcholine receptor studied in vitro and in transgenic mice. Neuroscience 69:807-819.
7. Boissiere F, Faucheux B, Agid Y and Hirsch EC (1997) Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease. Neurosci Lett 225:169-172.
8. Cerpa W, Dinamarca MC and Inestrosa NC (2008) Structurefunction implications in Alzheimer's disease: Effect of Abeta oligomers at central synapses. Curr Alzheimer Res 5:233-243.
9. Chen ZF, Paquette AJ and Anderson DJ (1998) NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis. Nat Genet 20:136-142.
10. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
11. Chong JA, Tapia-Ramirez J, Kim S, Toledo-Aral JJ, Zheng Y, Boutros MC, Altshuller YM, Frohman MA, Kraner SD and Mandel G (1995) REST: A mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80:949-957.
12. Coyle JT, Price DL and DeLong MR (1983) Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 219:1184-1190.
13. De Gois S, Houhou L, Oda Y, Corbex M, Pajak F, Thevenot E, Vodjdani G, Mallet J and Berrard S (2000) Is RE1/NRSE a common cis-regulatory sequence for ChAT and VAChT genes? J Biol Chem 275:36683-36690.
14. DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RA, Chui HC, Knopman DS, Reeder TM, Shetter AG, Senter HJ and Markesbery WR (1992) Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group. Ann Neurol 32:625-632.
15. Fibiger HC (1982) The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Res 257:327-388.
16. Garcia-Alloza M, Gil-Bea FJ, Diez-Ariza M, Chen CP, Francis PT, Lasheras B and Ramirez MJ (2005) Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Neuropsychologia 43:442-449.
17. Gaykema RP, Luiten PG, Nyakas C and Traber J (1990) Cortical projection patterns of the medial septum-diagonal band complex. J Comp Neurol 293:103-124.
18. Geula C, Nagykery N, Nicholas A and Wu CK (2008) Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J Neuropathol Exp Neurol 67:309-318.
19. Hahm SH, Chen L, Patel C, Erickson J, Bonner TI, Weihe E, Schafer MK and Eiden LE (1997) Upstream sequencing and functional characterization of the human cholinergic gene locus. J Mol Neurosci 9:223-236.
20. Haroutunian V, Schnaider-Beeri M, Schmeidler J, Wysocki M, Purohit DP, Perl DP, Libow LS, Lesser GT, Maroukian M and Grossman HT (2008) Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol 65:1211-1217.
21. Heese K and Akatsu H (2006) Alzheimer's disease - An interactive perspective. Curr Alzheimer Res 3:109-121.
22. Hersh LB and Shimojo M (2003) Regulation of cholinergic gene expression by the neuron restrictive silencer factor/repressor element-1 silencing transcription factor. Life Sci 72:2021-2028.
23. Ikonomovic MD, Mufson EJ, Wuu J, Bennett DA and DeKosky ST (2005) Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease. Arch Neurol 62:425-430.
24. Ikonomovic MD, Klunk WE, Abrahamson EE, Wuu J, Mathis CA, Scheff SW, Mufson EJ and DeKosky ST (2011) Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease. Neurology 77:39-47.
25. Jones BE (2004) Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex. Prog Brain Res 145:157-169.
26. Jones FS and Meech R (1999) Knockout of REST/NRSF shows that the protein is a potent repressor of neuronally expressed genes in non-neural tissues. Bioessays 21:372-376
27. Kar S, Slowikowski SP, Westaway D and Mount HT (2004) Interactions between beta-amyloid and central cholinergic neurons: Implications for Alzheimer's disease. J Psychiatry Neurosci 29:427-441.
28. Karczmar AG (1990) Physiological cholinergic functions in the CNS. Prog Brain Res 84:437-466.
29. Karczmar AG (1993) Brief presentation of the story and present status of studies of the vertebrate cholinergic system. Neuropsychopharmacology 9:181-199.
30. Lehericy S, Hirsch EC, Cervera-Pierot P, Hersh LB, Bakchine S, Piette F, Duyckaerts C, Hauw JJ, Javoy-Agid F and Agid Y (1993) Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J Comp Neurol 330:15-31.
31. Lewin B (2000) Transcription. In: Lewin B (ed) Genes VII. Oxford University Press and Cell Press, New York, pp 233-271.
32. Lonnerberg P, Schoenherr CJ, Anderson DJ and Ibanez CF (1996) Cell type-specific regulation of choline acetyltransferase gene expression. Role of the neuron-restrictive silencer element and cholinergic-specific enhancer sequences. J Biol Chem 271:33358-33365.
33. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
34. Luque JH and Hernández A (2002) Maduración del RNA o procesamiento postranscripcional. In: Biología Molecular e Ingeniería Genética. Harcourt/Gráficas Marte S.A, Madrid, pp 275-284.
35. Maccioni RB, Otth C, Concha II and Munoz JP (2001) The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur J Biochem 268:1518-1527.
36. Martin JB (1999) Molecular basis of the neurodegenerative disorders. N Engl J Med 340:1970-1980.
37. Martinez-Murillo R, Villalba R, Montero-Caballero MI and Rodrigo J (1989) Cholinergic somata and terminals in the rat substantia nigra: An immunocytochemical study with optical and electron microscopic techniques. J Comp Neurol 281:397-415.
38. Mesulam MM (1996) The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. Prog Brain Res 109:285-297.
39. Mesulam MM and Geula C (1988) Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol 275:216-240.
40. Mieda M, Haga T and Saffen DW (1997) Expression of the rat m4 muscarinic acetylcholine receptor gene is regulated by the neuron-restrictive silencer element/repressor element 1. J Biol Chem 272:5854-5860.
41. Mori N, Stein R, Sigmund O and Anderson DJ (1990) A cell type-preferred silencer element that controls the neural-specific expression of the SCG10 gene. Neuron 4:583-594.
42. Mori N, Schoenherr C, Vandenbergh DJ and Anderson DJ (1992) A common silencer element in the SCG10 and type II Na+ channel genes binds a factor present in nonneuronal cells but not in neuronal cells. Neuron 9:45-54.
43. Mufson EJ, Ginsberg SD, Ikonomovic MD and DeKosky ST (2003) Human cholinergic basal forebrain: Chemoanatomy and neurologic dysfunction. J Chem Neuroanat 26:233-242.
44. Nunes-Tavares N, Santos LE, Stutz B, Brito-Moreira J, Kein WL, Ferreira ST and de Mello FG (2012) Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-peptide oligomers. J Biol Chem 287:19377-19385.
45. Oda Y, Nakanishi I and Deguchi T (1992) A complementary DNA for human choline acetyltransferase induces two forms of enzyme with different molecular weights in cultured cells. Brain Res Mol Brain Res 16:287-294.
46. Oda Y, Muroishi Y and Nakanishi I (1996) Translation initiation sites and relative activity of large and small forms of human choline acetyltransferase. Brain Res Mol Brain Res 38:135-138.
47. Oda Y, Muroishi Y, Misawa H and Suzuki S (2004) Comparative study of gene expression of cholinergic system-related molecules in the human spinal cord and term placenta. Neuroscience 128:39-49.
48. Pakaski M and Kalman J (2008) Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease. Neurochem Int 53:103-111.
49. Palm K, Belluardo N, Metsis M and Timmusk T (1998) Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene. J Neurosci 18:1280-1296
50. Palm K, Metsis M and Timmusk T (1999) Neuron-specific splicing of zinc finger transcription factor REST/NRSF/XBR is frequent in neuroblastomas and conserved in human, mouse and rat. Brain Res Mol Brain Res 72:30-39.
51. Pepeu G (1993) Overview and future directions of CNS cholinergic mechanisms. Prog Brain Res 98:455-458.
52. Price DL (2000) Aging of the brain and dementia of the Alzheimer type. In: Kandel ER and Jessel TM (ed) Principles of Neural Sciences. McGraw-Hill, New York, pp 1149-1168.
53. Roopra A, Sharling L, Wood IC, Briggs T, Bachfischer U, Paquette AJ and Buckley NJ (2000) Transcriptional repression by neuron-restrictive silencer factor is mediated via the Sin3-histone deacetylase complex. Mol Cell Biol 20:2147-2157.
54. Schoenherr CJ and Anderson DJ (1995) The neuron-restrictive silencer factor (NRSF): A coordinate repressor of multiple neuron-specific genes. Science 267:1360-1363.
55. Schoenherr CJ, Paquette AJ and Anderson DJ (1996) Identification of potential target genes for the neuron-restrictive silencer factor. Proc Natl Acad Sci USA 93:9881-9886.
56. Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB and Mesulam MM (1998) Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 121:2249-2257.
57. Semba K, Reiner PB, McGeer EG and Fibiger HC (1989) Brainstem projecting neurons in the rat basal forebrain: Neurochemical, topographical, and physiological distinctions from cortically projecting cholinergic neurons. Brain Res Bull 22:501-509.
58. Shimojo M, Paquette AJ, Anderson DJ and Hersh LB (1999) Protein kinase A regulates cholinergic gene expression in PC12 cells: REST4 silences the silencing activity of neuron-restrictive silencer factor/REST. Mol Cell Biol 19:6788-6795.
59. Shimojo M, Wu D and Hersh LB (1998) The cholinergic gene locus is coordinately regulated by protein kinase A II in PC12 cells. J Neurochem 71:1118-1126.
60. Squire LR and Zola-Morgan S (1991) The medial temporal lobe memory system. Science 253:1380-1386.
61. Tanaka H, Zhao Y, Wu D and Hersh LB (1998) The use of DNase I hypersensitivity site mapping to identify regulatory regions of the human cholinergic gene locus. J Neurochem 70:1799-1808.
62. Thiel G, Schoch S and Petersohn D (1994) Regulation of synapsin I gene expression by the zinc finger transcription factor zif268/egr-1. J Biol Chem 269:15294-15301.
63. Timmusk T, Palm K, Lendahl U and Metsis M (1999) Brainderived neurotrophic factor expression in vivo is under the control of neuron-restrictive silencer element. J Biol Chem 274:1078-1084.
64. Watson D, Castaño E, Kokjohn TA, Kuo YM, Lyubchenko Y, Pinsky D, Connolly Jr ES, Esh C, Luehrs DC, Stine WB, et al. (2005). Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease. Neurol Res 27:869-881.
65. Wible CG, Shiber JR and Olton DS (1992) Hippocampus, fimbria-fornix, amygdala, and memory: Object discriminations in rats. Behav Neurosci 106:751-761.
66. Wilcock GK, Esiri MM, Bowen DM and Smith CC (1982) Alzheimer's disease. Correlation of cortical choline acetyltrans-ferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 57:407-417.
67. Wood IC, Belyaev ND, Bruce AW, Jones C, Mistry M, Roopra A and Buckley NJ (2003) Interaction of the repressor element 1-silencing transcription factor (REST) with target genes. J Mol Biol 334:863-874.
68. World Medical Association (2008) Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. In: W.M. Association, ed. 59th General Assembly, Seoul.
69. Yan Z and Feng J (2004) Alzheimer's disease: Interactions between cholinergic functions and beta-amyloid. Curr Alzheimer Res 1:241-248.